Page last updated: 2024-08-17

adenosine diphosphate and dmp 728

adenosine diphosphate has been researched along with dmp 728 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bozarth, JM; Diemer, M; Forsythe, MS; Mousa, SA; Reilly, TM1
DeGrado, WF; Kapil, RP; Lucchesi, BR; Mousa, SA; Mu, DX; Reilly, TM1
Faul, JD; Huang, J; Lucchesi, BR; Rebello, SS1

Other Studies

3 other study(ies) available for adenosine diphosphate and dmp 728

ArticleYear
Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
    Coronary artery disease, 1994, Volume: 5, Issue:11

    Topics: Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Clinical Protocols; Dogs; Drug Therapy, Combination; Female; Femoral Artery; Fibrinolysis; Hemodynamics; Humans; Male; Mesylates; Models, Cardiovascular; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding; Recurrence; Streptokinase; Thrombosis

1994
Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.
    Circulation, 1996, Feb-01, Volume: 93, Issue:3

    Topics: Adenosine Diphosphate; Administration, Oral; Anesthesia, General; Animals; Bleeding Time; Capsules; Coronary Thrombosis; Dogs; Female; Fibrinolytic Agents; In Vitro Techniques; Male; Mesylates; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex

1996
Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition.
    Pharmacology, 1999, Volume: 58, Issue:5

    Topics: Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arachidonic Acid; Bleeding Time; Blood Flow Velocity; Blood Platelets; Carotid Arteries; Carotid Artery Thrombosis; Citrates; Dogs; Dose-Response Relationship, Drug; Female; Heparin; Immunoglobulin Fab Fragments; Male; Mesylates; Mice; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine

1999